JP Patent

JP4606876B2 — ピラゾール誘導体、それを含有する医薬組成物及びその医薬用途

Assigned to Kissei Pharmaceutical Co Ltd · Expires 2011-01-05 · 15y expired

What this patent protects

Patent listed against Tradjenta.

Drugs covered by this patent

Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim

Patent Metadata

Patent number: JP4606876B2
Jurisdiction: JP
Classification: —
Expires: 2011-01-05
Drug substance claim: No
Drug product claim: No
Assignee: Kissei Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.